Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

NTRP

NextTrip (NTRP)

NextTrip Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTRP
DateHeureSourceTitreSymboleSociété
12/11/202423h31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NTRPNextTrip Inc
12/11/202422h42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NTRPNextTrip Inc
15/10/202422h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NTRPNextTrip Inc
31/05/202422h25Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:NTRPNextTrip Inc
04/02/202115h00PR Newswire (US)Synthetic Bryostatin Available to Expand Neurodegenerative Indication TrialsNASDAQ:NTRPNextTrip Inc
02/12/202015h00PR Newswire (US)Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros PharmaceuticalsNASDAQ:NTRPNextTrip Inc
02/12/202014h19Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NTRPNextTrip Inc
27/11/202023h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTRPNextTrip Inc
25/11/202023h15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTRPNextTrip Inc
24/11/202019h47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NTRPNextTrip Inc
20/11/202015h00PR Newswire (US)Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution DatesNASDAQ:NTRPNextTrip Inc
09/11/202023h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTRPNextTrip Inc
02/11/202023h20Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NTRPNextTrip Inc
06/10/202015h00PR Newswire (US)Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer's DiseaseNASDAQ:NTRPNextTrip Inc
30/09/202015h28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:NTRPNextTrip Inc
30/09/202015h15PR Newswire (US)Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with MetuchenNASDAQ:NTRPNextTrip Inc
30/07/202015h00PR Newswire (US)Neurotrope Bioscience Announces Agreement with Worldwide Clinical Trials, to Conduct Ongoing Phase 2 Study of Bryostatin-1, P...NASDAQ:NTRPNextTrip Inc
10/06/202014h41PR Newswire (US)Neurotrope Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the Nation...NASDAQ:NTRPNextTrip Inc
28/05/202015h00PR Newswire (US)Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Pa...NASDAQ:NTRPNextTrip Inc
26/05/202022h20PR Newswire (US)Neurotrope Announces Investor Update Conference CallNASDAQ:NTRPNextTrip Inc
18/05/202014h45PR Newswire (US)Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health CompanyNASDAQ:NTRPNextTrip Inc
27/04/202012h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NTRPNextTrip Inc
24/04/202023h17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:NTRPNextTrip Inc
17/04/202023h20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NTRPNextTrip Inc
13/03/202022h05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTRPNextTrip Inc
14/02/202016h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTRPNextTrip Inc
03/02/202023h15GlobeNewswire Inc.XpresSpa Appoints Robert Weinstein to Board of DirectorsNASDAQ:NTRPNextTrip Inc
31/01/202012h08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTRPNextTrip Inc
23/01/202015h31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NTRPNextTrip Inc
22/01/202020h05PR Newswire (US)Neurotrope, Inc. Announces $18 Million Registered Direct OfferingNASDAQ:NTRPNextTrip Inc
 Showing the most relevant articles for your search:NASDAQ:NTRP